Global Sucrose Benzoate Market
As the global economy mends, the 2021 growth of Sucrose Benzoate will have significant change fro ... Read More
Global Interleukin 1 (IL1) Market Growth 2024-2031
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interleukin 1 (IL1) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Interleukin 1 (IL1) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Interleukin 1 (IL1) by Country/Region, 2017, 2022 & 2028
2.2 Interleukin 1 (IL1) Segment by Type
2.2.1 APX-002
2.2.2 Canakinumab
2.2.3 Diacerein CR
2.2.4 IR-1000
2.2.5 Others
2.3 Interleukin 1 (IL1) Sales by Type
2.3.1 Global Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)
2.3.2 Global Interleukin 1 (IL1) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Interleukin 1 (IL1) Sale Price by Type (2017-2022)
2.4 Interleukin 1 (IL1) Segment by Application
2.4.1 Esophageal Cancer
2.4.2 Fallopian Tube Cancer
2.4.3 Bladder Cancer
2.4.4 Bechcer Disease
2.4.5 Others
2.5 Interleukin 1 (IL1) Sales by Application
2.5.1 Global Interleukin 1 (IL1) Sale Market Share by Application (2017-2022)
2.5.2 Global Interleukin 1 (IL1) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Interleukin 1 (IL1) Sale Price by Application (2017-2022)
3 Global Interleukin 1 (IL1) by Company
3.1 Global Interleukin 1 (IL1) Breakdown Data by Company
3.1.1 Global Interleukin 1 (IL1) Annual Sales by Company (2020-2022)
3.1.2 Global Interleukin 1 (IL1) Sales Market Share by Company (2020-2022)
3.2 Global Interleukin 1 (IL1) Annual Revenue by Company (2020-2022)
3.2.1 Global Interleukin 1 (IL1) Revenue by Company (2020-2022)
3.2.2 Global Interleukin 1 (IL1) Revenue Market Share by Company (2020-2022)
3.3 Global Interleukin 1 (IL1) Sale Price by Company
3.4 Key Manufacturers Interleukin 1 (IL1) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interleukin 1 (IL1) Product Location Distribution
3.4.2 Players Interleukin 1 (IL1) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Interleukin 1 (IL1) by Geographic Region
4.1 World Historic Interleukin 1 (IL1) Market Size by Geographic Region (2017-2022)
4.1.1 Global Interleukin 1 (IL1) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Interleukin 1 (IL1) Annual Revenue by Geographic Region
4.2 World Historic Interleukin 1 (IL1) Market Size by Country/Region (2017-2022)
4.2.1 Global Interleukin 1 (IL1) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Interleukin 1 (IL1) Annual Revenue by Country/Region
4.3 Americas Interleukin 1 (IL1) Sales Growth
4.4 APAC Interleukin 1 (IL1) Sales Growth
4.5 Europe Interleukin 1 (IL1) Sales Growth
4.6 Middle East & Africa Interleukin 1 (IL1) Sales Growth
5 Americas
5.1 Americas Interleukin 1 (IL1) Sales by Country
5.1.1 Americas Interleukin 1 (IL1) Sales by Country (2017-2022)
5.1.2 Americas Interleukin 1 (IL1) Revenue by Country (2017-2022)
5.2 Americas Interleukin 1 (IL1) Sales by Type
5.3 Americas Interleukin 1 (IL1) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interleukin 1 (IL1) Sales by Region
6.1.1 APAC Interleukin 1 (IL1) Sales by Region (2017-2022)
6.1.2 APAC Interleukin 1 (IL1) Revenue by Region (2017-2022)
6.2 APAC Interleukin 1 (IL1) Sales by Type
6.3 APAC Interleukin 1 (IL1) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Interleukin 1 (IL1) by Country
7.1.1 Europe Interleukin 1 (IL1) Sales by Country (2017-2022)
7.1.2 Europe Interleukin 1 (IL1) Revenue by Country (2017-2022)
7.2 Europe Interleukin 1 (IL1) Sales by Type
7.3 Europe Interleukin 1 (IL1) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interleukin 1 (IL1) by Country
8.1.1 Middle East & Africa Interleukin 1 (IL1) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2017-2022)
8.2 Middle East & Africa Interleukin 1 (IL1) Sales by Type
8.3 Middle East & Africa Interleukin 1 (IL1) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interleukin 1 (IL1)
10.3 Manufacturing Process Analysis of Interleukin 1 (IL1)
10.4 Industry Chain Structure of Interleukin 1 (IL1)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interleukin 1 (IL1) Distributors
11.3 Interleukin 1 (IL1) Customer
12 World Forecast Review for Interleukin 1 (IL1) by Geographic Region
12.1 Global Interleukin 1 (IL1) Market Size Forecast by Region
12.1.1 Global Interleukin 1 (IL1) Forecast by Region (2023-2028)
12.1.2 Global Interleukin 1 (IL1) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Interleukin 1 (IL1) Forecast by Type
12.7 Global Interleukin 1 (IL1) Forecast by Application
13 Key Players Analysis
13.1 Optimum Therapeutics LLC
13.1.1 Optimum Therapeutics LLC Company Information
13.1.2 Optimum Therapeutics LLC Interleukin 1 (IL1) Product Offered
13.1.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Optimum Therapeutics LLC Main Business Overview
13.1.5 Optimum Therapeutics LLC Latest Developments
13.2 Orphit SAS
13.2.1 Orphit SAS Company Information
13.2.2 Orphit SAS Interleukin 1 (IL1) Product Offered
13.2.3 Orphit SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Orphit SAS Main Business Overview
13.2.5 Orphit SAS Latest Developments
13.3 Peptinov SAS
13.3.1 Peptinov SAS Company Information
13.3.2 Peptinov SAS Interleukin 1 (IL1) Product Offered
13.3.3 Peptinov SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Peptinov SAS Main Business Overview
13.3.5 Peptinov SAS Latest Developments
13.4 AbbVie Inc
13.4.1 AbbVie Inc Company Information
13.4.2 AbbVie Inc Interleukin 1 (IL1) Product Offered
13.4.3 AbbVie Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AbbVie Inc Main Business Overview
13.4.5 AbbVie Inc Latest Developments
13.5 Swedish Orphan Biovitrum AB
13.5.1 Swedish Orphan Biovitrum AB Company Information
13.5.2 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Offered
13.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Swedish Orphan Biovitrum AB Main Business Overview
13.5.5 Swedish Orphan Biovitrum AB Latest Developments
13.6 TWi Biotechnology Inc
13.6.1 TWi Biotechnology Inc Company Information
13.6.2 TWi Biotechnology Inc Interleukin 1 (IL1) Product Offered
13.6.3 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 TWi Biotechnology Inc Main Business Overview
13.6.5 TWi Biotechnology Inc Latest Developments
13.7 XBiotech Inc
13.7.1 XBiotech Inc Company Information
13.7.2 XBiotech Inc Interleukin 1 (IL1) Product Offered
13.7.3 XBiotech Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 XBiotech Inc Main Business Overview
13.7.5 XBiotech Inc Latest Developments
13.8 Cell Medica Ltd
13.8.1 Cell Medica Ltd Company Information
13.8.2 Cell Medica Ltd Interleukin 1 (IL1) Product Offered
13.8.3 Cell Medica Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Cell Medica Ltd Main Business Overview
13.8.5 Cell Medica Ltd Latest Developments
13.9 Exicure Inc
13.9.1 Exicure Inc Company Information
13.9.2 Exicure Inc Interleukin 1 (IL1) Product Offered
13.9.3 Exicure Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Exicure Inc Main Business Overview
13.9.5 Exicure Inc Latest Developments
13.10 Immune Response BioPharma Inc
13.10.1 Immune Response BioPharma Inc Company Information
13.10.2 Immune Response BioPharma Inc Interleukin 1 (IL1) Product Offered
13.10.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Immune Response BioPharma Inc Main Business Overview
13.10.5 Immune Response BioPharma Inc Latest Developments
13.11 Novartis AG
13.11.1 Novartis AG Company Information
13.11.2 Novartis AG Interleukin 1 (IL1) Product Offered
13.11.3 Novartis AG Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Novartis AG Main Business Overview
13.11.5 Novartis AG Latest Developments
13.12 Omnitura Therapeutics Inc
13.12.1 Omnitura Therapeutics Inc Company Information
13.12.2 Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Offered
13.12.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Omnitura Therapeutics Inc Main Business Overview
13.12.5 Omnitura Therapeutics Inc Latest Developments
13.13 Opsona Therapeutics Ltd
13.13.1 Opsona Therapeutics Ltd Company Information
13.13.2 Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Offered
13.13.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Opsona Therapeutics Ltd Main Business Overview
13.13.5 Opsona Therapeutics Ltd Latest Developments
13.14 Anacor Pharmaceuticals Inc
13.14.1 Anacor Pharmaceuticals Inc Company Information
13.14.2 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered
13.14.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Anacor Pharmaceuticals Inc Main Business Overview
13.14.5 Anacor Pharmaceuticals Inc Latest Developments
13.15 Apexigen Inc
13.15.1 Apexigen Inc Company Information
13.15.2 Apexigen Inc Interleukin 1 (IL1) Product Offered
13.15.3 Apexigen Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Apexigen Inc Main Business Overview
13.15.5 Apexigen Inc Latest Developments
13.16 R Pharm
13.16.1 R Pharm Company Information
13.16.2 R Pharm Interleukin 1 (IL1) Product Offered
13.16.3 R Pharm Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 R Pharm Main Business Overview
13.16.5 R Pharm Latest Developments
13.17 Regeneron Pharmaceuticals Inc
13.17.1 Regeneron Pharmaceuticals Inc Company Information
13.17.2 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered
13.17.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Regeneron Pharmaceuticals Inc Main Business Overview
13.17.5 Regeneron Pharmaceuticals Inc Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Interleukin 1 (IL1) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Interleukin 1 (IL1) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of APX-002
Table 4. Major Players of Canakinumab
Table 5. Major Players of Diacerein CR
Table 6. Major Players of IR-1000
Table 7. Major Players of Others
Table 8. Global Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)
Table 10. Global Interleukin 1 (IL1) Revenue by Type (2017-2022) & ($ million)
Table 11. Global Interleukin 1 (IL1) Revenue Market Share by Type (2017-2022)
Table 12. Global Interleukin 1 (IL1) Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)
Table 15. Global Interleukin 1 (IL1) Revenue by Application (2017-2022)
Table 16. Global Interleukin 1 (IL1) Revenue Market Share by Application (2017-2022)
Table 17. Global Interleukin 1 (IL1) Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Interleukin 1 (IL1) Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Interleukin 1 (IL1) Sales Market Share by Company (2020-2022)
Table 20. Global Interleukin 1 (IL1) Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Interleukin 1 (IL1) Revenue Market Share by Company (2020-2022)
Table 22. Global Interleukin 1 (IL1) Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Interleukin 1 (IL1) Producing Area Distribution and Sales Area
Table 24. Players Interleukin 1 (IL1) Products Offered
Table 25. Interleukin 1 (IL1) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Interleukin 1 (IL1) Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Interleukin 1 (IL1) Sales Market Share Geographic Region (2017-2022)
Table 30. Global Interleukin 1 (IL1) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Interleukin 1 (IL1) Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Interleukin 1 (IL1) Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Interleukin 1 (IL1) Sales Market Share by Country/Region (2017-2022)
Table 34. Global Interleukin 1 (IL1) Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Interleukin 1 (IL1) Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Interleukin 1 (IL1) Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Interleukin 1 (IL1) Sales Market Share by Country (2017-2022)
Table 38. Americas Interleukin 1 (IL1) Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Interleukin 1 (IL1) Revenue Market Share by Country (2017-2022)
Table 40. Americas Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)
Table 42. Americas Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)
Table 44. APAC Interleukin 1 (IL1) Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Interleukin 1 (IL1) Sales Market Share by Region (2017-2022)
Table 46. APAC Interleukin 1 (IL1) Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Interleukin 1 (IL1) Revenue Market Share by Region (2017-2022)
Table 48. APAC Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)
Table 50. APAC Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)
Table 52. Europe Interleukin 1 (IL1) Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Interleukin 1 (IL1) Sales Market Share by Country (2017-2022)
Table 54. Europe Interleukin 1 (IL1) Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Interleukin 1 (IL1) Revenue Market Share by Country (2017-2022)
Table 56. Europe Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)
Table 58. Europe Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Interleukin 1 (IL1) Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Interleukin 1 (IL1) Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Interleukin 1 (IL1)
Table 69. Key Market Challenges & Risks of Interleukin 1 (IL1)
Table 70. Key Industry Trends of Interleukin 1 (IL1)
Table 71. Interleukin 1 (IL1) Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Interleukin 1 (IL1) Distributors List
Table 74. Interleukin 1 (IL1) Customer List
Table 75. Global Interleukin 1 (IL1) Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Interleukin 1 (IL1) Sales Market Forecast by Region
Table 77. Global Interleukin 1 (IL1) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Interleukin 1 (IL1) Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Interleukin 1 (IL1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Interleukin 1 (IL1) Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Interleukin 1 (IL1) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Interleukin 1 (IL1) Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Interleukin 1 (IL1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Interleukin 1 (IL1) Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Interleukin 1 (IL1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Interleukin 1 (IL1) Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Interleukin 1 (IL1) Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Interleukin 1 (IL1) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Interleukin 1 (IL1) Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Interleukin 1 (IL1) Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Interleukin 1 (IL1) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Application (2023-2028)
Table 95. Optimum Therapeutics LLC Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 96. Optimum Therapeutics LLC Interleukin 1 (IL1) Product Offered
Table 97. Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Optimum Therapeutics LLC Main Business
Table 99. Optimum Therapeutics LLC Latest Developments
Table 100. Orphit SAS Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 101. Orphit SAS Interleukin 1 (IL1) Product Offered
Table 102. Orphit SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Orphit SAS Main Business
Table 104. Orphit SAS Latest Developments
Table 105. Peptinov SAS Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 106. Peptinov SAS Interleukin 1 (IL1) Product Offered
Table 107. Peptinov SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Peptinov SAS Main Business
Table 109. Peptinov SAS Latest Developments
Table 110. AbbVie Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 111. AbbVie Inc Interleukin 1 (IL1) Product Offered
Table 112. AbbVie Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. AbbVie Inc Main Business
Table 114. AbbVie Inc Latest Developments
Table 115. Swedish Orphan Biovitrum AB Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 116. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Offered
Table 117. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Swedish Orphan Biovitrum AB Main Business
Table 119. Swedish Orphan Biovitrum AB Latest Developments
Table 120. TWi Biotechnology Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 121. TWi Biotechnology Inc Interleukin 1 (IL1) Product Offered
Table 122. TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. TWi Biotechnology Inc Main Business
Table 124. TWi Biotechnology Inc Latest Developments
Table 125. XBiotech Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 126. XBiotech Inc Interleukin 1 (IL1) Product Offered
Table 127. XBiotech Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. XBiotech Inc Main Business
Table 129. XBiotech Inc Latest Developments
Table 130. Cell Medica Ltd Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 131. Cell Medica Ltd Interleukin 1 (IL1) Product Offered
Table 132. Cell Medica Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Cell Medica Ltd Main Business
Table 134. Cell Medica Ltd Latest Developments
Table 135. Exicure Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 136. Exicure Inc Interleukin 1 (IL1) Product Offered
Table 137. Exicure Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Exicure Inc Main Business
Table 139. Exicure Inc Latest Developments
Table 140. Immune Response BioPharma Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 141. Immune Response BioPharma Inc Interleukin 1 (IL1) Product Offered
Table 142. Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Immune Response BioPharma Inc Main Business
Table 144. Immune Response BioPharma Inc Latest Developments
Table 145. Novartis AG Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 146. Novartis AG Interleukin 1 (IL1) Product Offered
Table 147. Novartis AG Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Novartis AG Main Business
Table 149. Novartis AG Latest Developments
Table 150. Omnitura Therapeutics Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 151. Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Offered
Table 152. Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Omnitura Therapeutics Inc Main Business
Table 154. Omnitura Therapeutics Inc Latest Developments
Table 155. Opsona Therapeutics Ltd Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 156. Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Offered
Table 157. Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. Opsona Therapeutics Ltd Main Business
Table 159. Opsona Therapeutics Ltd Latest Developments
Table 160. Anacor Pharmaceuticals Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 161. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered
Table 162. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Anacor Pharmaceuticals Inc Main Business
Table 164. Anacor Pharmaceuticals Inc Latest Developments
Table 165. Apexigen Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 166. Apexigen Inc Interleukin 1 (IL1) Product Offered
Table 167. Apexigen Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 168. Apexigen Inc Main Business
Table 169. Apexigen Inc Latest Developments
Table 170. R Pharm Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 171. R Pharm Interleukin 1 (IL1) Product Offered
Table 172. R Pharm Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 173. R Pharm Main Business
Table 174. R Pharm Latest Developments
Table 175. Regeneron Pharmaceuticals Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors
Table 176. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered
Table 177. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 178. Regeneron Pharmaceuticals Inc Main Business
Table 179. Regeneron Pharmaceuticals Inc Latest Developments
List of Figures
Figure 1. Picture of Interleukin 1 (IL1)
Figure 2. Interleukin 1 (IL1) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interleukin 1 (IL1) Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Interleukin 1 (IL1) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Interleukin 1 (IL1) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of APX-002
Figure 10. Product Picture of Canakinumab
Figure 11. Product Picture of Diacerein CR
Figure 12. Product Picture of IR-1000
Figure 13. Product Picture of Others
Figure 14. Global Interleukin 1 (IL1) Sales Market Share by Type in 2021
Figure 15. Global Interleukin 1 (IL1) Revenue Market Share by Type (2017-2022)
Figure 16. Interleukin 1 (IL1) Consumed in Esophageal Cancer
Figure 17. Global Interleukin 1 (IL1) Market: Esophageal Cancer (2017-2022) & (K Pcs)
Figure 18. Interleukin 1 (IL1) Consumed in Fallopian Tube Cancer
Figure 19. Global Interleukin 1 (IL1) Market: Fallopian Tube Cancer (2017-2022) & (K Pcs)
Figure 20. Interleukin 1 (IL1) Consumed in Bladder Cancer
Figure 21. Global Interleukin 1 (IL1) Market: Bladder Cancer (2017-2022) & (K Pcs)
Figure 22. Interleukin 1 (IL1) Consumed in Bechcer Disease
Figure 23. Global Interleukin 1 (IL1) Market: Bechcer Disease (2017-2022) & (K Pcs)
Figure 24. Interleukin 1 (IL1) Consumed in Others
Figure 25. Global Interleukin 1 (IL1) Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)
Figure 27. Global Interleukin 1 (IL1) Revenue Market Share by Application in 2021
Figure 28. Interleukin 1 (IL1) Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Interleukin 1 (IL1) Revenue Market Share by Company in 2021
Figure 30. Global Interleukin 1 (IL1) Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Interleukin 1 (IL1) Revenue Market Share by Geographic Region in 2021
Figure 32. Global Interleukin 1 (IL1) Sales Market Share by Region (2017-2022)
Figure 33. Global Interleukin 1 (IL1) Revenue Market Share by Country/Region in 2021
Figure 34. Americas Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)
Figure 35. Americas Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)
Figure 36. APAC Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)
Figure 37. APAC Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)
Figure 38. Europe Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)
Figure 39. Europe Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)
Figure 42. Americas Interleukin 1 (IL1) Sales Market Share by Country in 2021
Figure 43. Americas Interleukin 1 (IL1) Revenue Market Share by Country in 2021
Figure 44. United States Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Interleukin 1 (IL1) Sales Market Share by Region in 2021
Figure 49. APAC Interleukin 1 (IL1) Revenue Market Share by Regions in 2021
Figure 50. China Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Interleukin 1 (IL1) Sales Market Share by Country in 2021
Figure 57. Europe Interleukin 1 (IL1) Revenue Market Share by Country in 2021
Figure 58. Germany Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Interleukin 1 (IL1) Revenue Market Share by Country in 2021
Figure 65. Egypt Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Interleukin 1 (IL1) in 2021
Figure 71. Manufacturing Process Analysis of Interleukin 1 (IL1)
Figure 72. Industry Chain Structure of Interleukin 1 (IL1)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Please ask for List of Figures. Request Sample Report